SCHEMBL23740434

SCHEMBL23740434

c1ccc(-c2ccc(-c3nc(-c4cccc5oc6cc(-n7c8ccccc8c8cc9ccccc9cc87)ccc6c45)nc4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.33
MAPT P10636 8/20 0.32
ALDH1A1 P00352 4/20 0.32
LMNA P02545 4/20 0.32
KDM4E B2RXH2 3/20 0.32
HSD17B10 Q99714 2/20 0.32
POLB P06746 2/20 0.32
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
MAPK1 P28482 1/20 0.32
HPGD P15428 1/20 0.32
KMT2A Q03164 4/20 0.31
MEN1 O00255 3/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CSF1R P07333 1/20 0.31
PDGFRB P09619 1/20 0.31
KIT P10721 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415865 0.98 TSHR (0.34) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL26415871 0.94 MAPT (0.37) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL24118962 0.94 ALDH1A1 (0.34) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL23740355 0.90 PIM1 (0.37) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL26415887 0.89 TSHR (0.33) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL26416933 0.89 TSHR (0.36) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL22195514 0.88 TSHR (0.39) TSHRMAPTALDH1A1LMNAKDM4E
SCHEMBL21863023 0.88 PTGER4 (0.31) TSHRMAPTALDH1A1KDM4EHSD17B10
SCHEMBL26415822 0.88 PTGER4 (0.31) TSHRMAPTALDH1A1KDM4EHSD17B10
SCHEMBL21863121 0.87 NPC1 (0.34) TSHRMAPTALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-12-23 US disclosed
EP-3862353-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT Materials Co., Ltd. (KR) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 TSHR 3795/4885MAPT 967/4885ALDH1A1 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.